Get the Stockscreener App
1.03
3.74%
-0.04
Lucid Diagnostics Inc stock is traded at $1.03, with a volume of 1.29M.
It is down -3.74% in the last 24 hours and up +3.26% over the past month.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
See More
Previous Close:
$1.07
Open:
$1.08
24h Volume:
1.29M
Relative Volume:
1.04
Market Cap:
$111.73M
Revenue:
$4.35M
Net Income/Loss:
$-45.53M
P/E Ratio:
-0.9537
EPS:
-1.08
Net Cash Flow:
$-44.79M
1W Performance:
-24.82%
1M Performance:
+3.26%
6M Performance:
-21.97%
1Y Performance:
+23.26%
1-Day Range:
$1.03
$1.0875
1-Week Range:
$1.01
$1.3864
52-Week Range:
$0.73
$1.80
Lucid Diagnostics Inc Stock (LUCD) Company Profile
Name
Lucid Diagnostics Inc
Sector
Industry
Phone
212 949 4319
Address
360 MADISON AVENUE, NEW YORK
Compare LUCD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LUCD
Lucid Diagnostics Inc
|
1.03 | 103.93M | 4.35M | -45.53M | -44.79M | -1.08 |
|
ABT
Abbott Laboratories
|
133.73 | 225.15B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.71 | 155.92B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
383.34 | 146.41B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
94.03 | 118.42B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
77.57 | 45.96B | 5.69B | 1.41B | 577.90M | 6.95 |
Lucid Diagnostics Inc Stock (LUCD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-27-21 | Initiated | Ascendiant Capital Markets | Buy |
| Nov-08-21 | Initiated | BTIG Research | Buy |
| Nov-08-21 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-08-21 | Initiated | Needham | Buy |
Lucid Diagnostics Inc Stock (LUCD) Latest News
Duke University to License Endoscopic Esophageal Imaging Tech to PAVmed - Medical Product Outsourcing
Lucid Diagnostics dips after pricing $25M stock offering - MSN
Lucid Diagnostics Completes Public Offering for $26.9 Million - The Globe and Mail
Alyeska Investment Group L.P. Makes New $2.81 Million Investment in Lucid Diagnostics Inc. $LUCD - MarketBeat
Lucid Diagnostics announces proposed public offering of common stock - MSN
Lucid Diagnostics Announces Public Stock Offering - MSN
Lucid Diagnostics announces closing of public offering of common stock - MarketScreener
Lucid Diagnostics Closes Roughly $26.9 Million Stock Offering - MarketScreener
PAVmed’s Lucid Diagnostics Completes Public Stock Offering - TipRanks
$26.9M Capital Raise: Cancer Diagnostics Firm Lucid Completes Major Public Offering at $1.00 Per Share - Stock Titan
Lucid Diagnostics stock maintains Buy rating at BTIG after $25M raise - Investing.com Canada
Lucid Diagnostics Prices $25 Mln Public Offering At $1.00 Per Share - Nasdaq
Lucid Diagnostics Shares Fall After Pricing of Public Stock Offering - 富途牛牛
Lucid Diagnostics stock maintains Buy rating at BTIG after $25M raise By Investing.com - Investing.com South Africa
Lucid Diagnostics prices $25 million public offering of common stock - Investing.com
Lucid Prices Public Share Offering - Baystreet.ca
Lucid Diagnostics Prices $25 Million Public Offering - MarketScreener
Lucid Diagnostics Announces Pricing of Public Offering of Common Stock - PR Newswire
Lucid Diagnostics prices $25 million public offering of common stock By Investing.com - Investing.com UK
Lucid Diagnostics announces pricing of public offering of common stock - MarketScreener
$25 Million Stock Offering: Cancer Diagnostics Firm Lucid Diagnostics Raises Fresh Capital at $1/Share - Stock Titan
Lucid Diagnostics announces proposed public offering of common stock By Investing.com - Investing.com Australia
Lucid Diagnostics Plans Stock Offering - MarketScreener
Medical Diagnostics Company Lucid Diagnostics Plans New Stock Offering to Fund Growth - Stock Titan
Sentiment Watch: What’s the MACD signal for Lucid Diagnostics Inc.Quarterly Performance Summary & Long-Term Growth Stock Strategies - Lancaster City Council
Is Lucid Diagnostics Inc. stock forming a cup and handleQuarterly Trade Summary & Technical Buy Zone Confirmations - beatles.ru
Transcript : Lucid Diagnostics Inc.Special Call - MarketScreener
Lucid Diagnostics Advances Towards Medicare Coverage - MSN
Lucid Diagnostics to Host Investor Call on Monday, September 8, 2025 - BioSpace
Will Lucid Diagnostics Inc. outperform during market ralliesRate Cut & Weekly Top Gainers Trade List - خودرو بانک
Lucid Diagnostics stock rises as Canaccord reiterates Buy rating By Investing.com - Investing.com Nigeria
Detecting support and resistance levels for Lucid Diagnostics Inc.Rate Hike & AI Powered Buy and Sell Recommendations - Newser
Will Lucid Diagnostics Inc. bounce back from current supportJuly 2025 Selloffs & Verified High Yield Trade Plans - Newser
How to build a custom watchlist for Lucid Diagnostics Inc.2025 Price Action Summary & Expert Curated Trade Ideas - Newser
Needham reiterates Buy rating on Lucid Diagnostics stock after positive CAC meeting - Investing.com Nigeria
Lucid Diagnostics at Cantor Conference: Path to Medicare Coverage By Investing.com - Investing.com Canada
Lucid Diagnostics at Cantor Conference: Path to Medicare Coverage - Investing.com India
Lucid Diagnostics To Host Investor Call On Monday, September 8, 2025 - Barchart.com
BTIG raises Lucid Diagnostics stock price target to $2.50 on positive CMS meeting By Investing.com - Investing.com South Africa
Will Lucid Diagnostics Inc. continue its uptrendCEO Change & Weekly Market Pulse Updates - Newser
BTIG raises Lucid Diagnostics stock price target to $2.50 on positive CMS meeting - Investing.com India
Lucid Diagnostics stock rises as Canaccord reiterates Buy rating - Investing.com
Published on: 2025-09-05 05:06:12 - Newser
Ghisallo Capital Management LLC Makes New Investment in Lucid Diagnostics Inc. $LUCD - MarketBeat
Strategies to average down on Lucid Diagnostics Inc.2025 Year in Review & Fast Exit and Entry Strategy Plans - Newser
How to read the order book for Lucid Diagnostics Inc.2025 Trade Ideas & High Conviction Investment Ideas - Newser
What technical models suggest about Lucid Diagnostics Inc.’s comebackTrade Volume Summary & Growth Focused Investment Plans - Newser
Lucid Diagnostics Inc Stock (LUCD) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.14%
1.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):